“Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis ”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024047, Apr. 2024, doi: 10.4084/MJHID.2024.047.